Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 644

1.

Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.

Viereck V, Siggelkow H, Tauber S, Raddatz D, Schutze N, Hüfner M.

J Cell Biochem. 2002;86(2):348-56.

PMID:
12112004
5.

Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts.

Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, Bodine PV, Komm BS.

J Cell Biochem. 2001;80(3):424-40.

PMID:
11135373
6.

Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.

Luppen CA, Smith E, Spevak L, Boskey AL, Frenkel B.

J Bone Miner Res. 2003 Jul;18(7):1186-97.

7.
8.
9.

Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.

Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM.

J Cell Biochem. 1999 Apr 1;73(1):114-25.

PMID:
10088730
10.
11.

Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.

Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM.

Cancer Res. 2001 Jul 15;61(14):5652-9.

12.

Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.

Gu K, Zhang L, Jin T, Rutherford RB.

Cells Tissues Organs. 2004;176(1-3):28-40.

PMID:
14745233
13.

Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.

Tou L, Quibria N, Alexander JM.

Mol Cell Endocrinol. 2003 Jul 31;205(1-2):121-9.

PMID:
12890574
14.

Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha.

Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS.

J Biol Chem. 2002 Jan 25;277(4):2695-701. Epub 2001 Nov 26.

15.

Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.

Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Galléa S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G.

Bone. 2001 Oct;29(4):323-30.

PMID:
11595614
17.

Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.

Shalhoub V, Conlon D, Tassinari M, Quinn C, Partridge N, Stein GS, Lian JB.

J Cell Biochem. 1992 Dec;50(4):425-40.

PMID:
1469073
18.

Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression.

Xiao G, Jiang D, Ge C, Zhao Z, Lai Y, Boules H, Phimphilai M, Yang X, Karsenty G, Franceschi RT.

J Biol Chem. 2005 Sep 2;280(35):30689-96. Epub 2005 Jul 5.

Supplemental Content

Support Center